By: Liu Jia, Chinese Academy of Sciences From: medicalxpress.com In a study published in Cell Chemical Biology, a research team led by Prof. Tan Weihong and Prof. Wu Qin from the Hangzhou Institute of Medical of the Chinese Academy of Sciences has identified protein arginine methyltransferases (PRMTs), crucial regulators of RNA splicing and chromatin stability, as a new therapeutic target …
-
-
A World Turned Upside Down After a Breast Cancer Diagnosis
-
This Breast Cancer Survivor Won’t Settle for Being Mediocre
-
Please Don’t Tell a Breast Cancer Survivor What To Do
-
What is the meaning of “Labor Day” to Someone as a Breast Cancer Survivor
-
Learning to “Fire a Friend” After a Breast Cancer Diagnosis
